The NYT has an article reporting on how test results on Zetia, a new cholesterol lowering drug, were hidden or misrepresented. It never mentions the incentives given by patent protection for this sort of corruption. There are alternatives to patent protection for financing drug research. It is remarkable that this never gets mentioned in news reporting. The distortions created by patent protection for prescription drugs dwarf the distortions created by the protectionist measures that "free traders" focus their sights on.
We’re in the final stretch of our spring fundraising campaign and we’re not on pace to hit our goal. The truth is, we can’t keep producing independent journalism like this without support from readers like you. We don’t take ads from corporate giants or money from billionaires. That means we rely entirely on small donations to keep the lights on and the reporting strong. If you value journalism that challenges power, informs the public, and operates free from influence, now is the time to give.
